(INMB) – Management Comments
-
INmune Bio (INMB) Provides Update Regarding Global Alzheimer’s Phase II Clinical Trial and Clinical Hold Issued by the FDA
-
INmune Bio (INMB) Reports Q4, Provides Business Update
-
-
-
-
-
-
-
-
-
Back to INMB Stock Lookup